InvestSMART

Neurotech International Limited (ASX: NTI) - Announcements

- Current share price for NTI : $0.014

ASX company news and announcements for Neurotech International Limited (NTI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Neurotech International Limited (NTI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Neurotech International Limited (NTI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Neurotech International Limited (NTI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Change of Director's Interest Notice 20 Jul 2021 5:05PM $0.055 $0.014 fallen by 74.55%
$23 Change of Director's Interest Notice 15 Jul 2021 6:44PM $0.056 $0.014 fallen by 75%
$23 Further Success with Preclinical Testing Program - MS Models 7 Jul 2021 9:29AM $0.056 $0.014 fallen by 75%
$23 Appendix 3G 1 Jul 2021 9:25AM $0.053 $0.014 fallen by 73.58%
$23 Update - Proposed issue of securities - NTI 29 Jun 2021 5:19PM $0.058 $0.014 fallen by 75.86%
$23 NTI to Present at the Gold Coast Investment Showcase 23 Jun 2021 9:46AM $0.055 $0.014 fallen by 74.55%
$23 Change of Director's Interest Notice 23 Jun 2021 9:43AM $0.055 $0.014 fallen by 74.55%
$23 Investor Presentation 16 Jun 2021 8:19AM $0.054 $0.014 fallen by 74.07%
$23 NTI Strains Demonstrate Potential Benefits for MS Management 25 May 2021 9:03AM $0.058 $0.014 fallen by 75.86%
$23 Proposed issue of Securities - NTI 20 May 2021 9:16AM $0.057 $0.014 fallen by 75.44%
$23 Initial Director's Interest Notice 20 May 2021 9:12AM $0.057 $0.014 fallen by 75.44%
$23 Appointment of Allan Cripps as Non-Executive Director 20 May 2021 9:09AM $0.057 $0.014 fallen by 75.44%
$23 Appendix 2A 19 May 2021 5:06PM $0.057 $0.014 fallen by 75.44%
$23 Appendix 2A 12 May 2021 6:23PM $0.058 $0.014 fallen by 75.86%
$23 Update - Proposed issue of Securities - NTI 12 May 2021 6:08PM $0.058 $0.014 fallen by 75.86%
$23 Update - Proposed issue of Securities - NTI 12 May 2021 5:58PM $0.058 $0.014 fallen by 75.86%
$23 Results of Meeting 7 May 2021 1:30PM $0.058 $0.014 fallen by 75.86%
$23 Neurotech initiates Phase I/II Open Label Study into Autism 5 May 2021 9:16AM $0.064 $0.014 fallen by 78.13%
$23 Quarterly Report and Appendix 4C 3 May 2021 8:06AM $0.062 $0.014 fallen by 77.42%
$23 Update - Proposed issue of Securities - NTI 23 Apr 2021 9:22AM $0.061 $0.014 fallen by 77.05%
$23 Proposed issue of Securities - NTI 19 Apr 2021 9:45AM $0.068 $0.014 fallen by 79.41%
$23 Disclosure Document 19 Apr 2021 9:37AM $0.068 $0.014 fallen by 79.41%
$23 Appendix 2A 16 Apr 2021 6:42PM $0.068 $0.014 fallen by 79.41%
$23 Change of Director's Interest Notice 15 Apr 2021 6:50PM $0.068 $0.014 fallen by 79.41%
$23 Initial Director's Interest Notice 12 Apr 2021 4:40PM $0.074 $0.014 fallen by 81.08%

376 - 400 of 694 results

Page 16 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.